dc.contributor.author
Fuster, Carla
dc.contributor.author
Martín García, David
dc.contributor.author
Balagué, Olga
dc.contributor.author
Navarro, Alba
dc.contributor.author
Nadeu Prat, Ferran
dc.contributor.author
Costa, Dolors
dc.contributor.author
Prieto, Miriam
dc.contributor.author
Salaverria Frigola, Itziar
dc.contributor.author
Espinet Solà, Blanca
dc.contributor.author
Rivas Delgado, Alfredo
dc.contributor.author
Terol, Maria José
dc.contributor.author
Giné Soca, Eva
dc.contributor.author
Forcada, Pilar
dc.contributor.author
Ashton-Key, Margaret
dc.contributor.author
Puente, Xose S.
dc.contributor.author
Swerdlow, Steven H.
dc.contributor.author
Beà Bobet, Sílvia M.
dc.contributor.author
Campo Güerri, Elias
dc.date.issued
2020-03-03T15:07:25Z
dc.date.issued
2020-03-03T15:07:25Z
dc.date.issued
2019-01-01
dc.date.issued
2020-01-08T09:21:10Z
dc.identifier
https://hdl.handle.net/2445/151846
dc.description.abstract
Cyclin D1+ mantle cell lymphoma (MCL) is molecularly characterized by the
t(11;14)(q13;q32) or rearrangements of CCND1 gene with the immunoglobulin (IG)
light chains.1,2 Most MCL can be diagnosed based on the characteristic pathologic
features and cyclin D1 expression without the need for demonstrating the genetic
translocation. However, in cases with atypical morphologic or phenotypic features
other B-cell neoplasms that sometimes also have cyclin D1 positivity may be in the
differential diagnosis.1
In these situations the detection of the CCND1 rearrangements
may assist in the diagnosis since most other lymphomas do not carry translocations of
the gene.3-7 A subset of plasma cell myelomas express cyclin D1 associated with the
t(11;14) but are usually not in the differential diagnosis of MCL and are SOX11-
negative.5
Nevertheless, there are occasional lymphoid neoplasms with MCL features
in which cyclin D1 is strongly expressed without an apparent gene rearrangement
using conventional cytogenetics or fluorescence in situ hybridization (FISH) with fusion
or break-apart probes. The mechanisms of cyclin D1 overexpression in these cases are
unclear and the MCL diagnosis may be questioned.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Ferrata Storti Foundation
dc.relation
Versió postprint del document publicat a: https://doi.org/10.3324/haematol.2019.237073
dc.relation
Haematologica, 2019
dc.relation
https://doi.org/10.3324/haematol.2019.237073
dc.rights
(c) Ferrata Storti Foundation, 2019
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject
Malaltia de Hodgkin
dc.subject
Hodgkin's disease
dc.title
Cryptic Insertions Of The Immunoglobulin Light Chain Enhancer Region Near CCND1 In T(11;14)-Negative Mantle Cell Lymphoma
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion